Real-World Clinician Adherence to Screening and Preventive Practices Guidelines for Subsequent Neoplasms Among Allogeneic Hematopoietic Cell Transplant Survivors in the United States
Conferences
Bhatt, NS; Hellewell, EM; Ng, K; Gooley, T; Sung, AD; Taylor, AO; Hong, S; Ahmed, N; Morey, C; Fitzmaurice, S; Kennedy, VE; Lauer, M; Hill, L ...
Published in: Blood
November 5, 2024
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
Blood
DOI
EISSN
1528-0020
ISSN
0006-4971
Publication Date
November 5, 2024
Volume
144
Issue
Supplement 1
Start / End Page
4921 / 4921
Publisher
American Society of Hematology
Related Subject Headings
- Immunology
- 3213 Paediatrics
- 3201 Cardiovascular medicine and haematology
- 3101 Biochemistry and cell biology
Citation
APA
Chicago
ICMJE
MLA
NLM
Bhatt, N. S., Hellewell, E. M., Ng, K., Gooley, T., Sung, A. D., Taylor, A. O., … Lee, C. J. (2024). Real-World Clinician Adherence to Screening and Preventive Practices Guidelines for Subsequent Neoplasms Among Allogeneic Hematopoietic Cell Transplant Survivors in the United States. In Blood (Vol. 144, pp. 4921–4921). American Society of Hematology. https://doi.org/10.1182/blood-2024-199289
Bhatt, Neel S., Elizabeth M. Hellewell, Kevin Ng, Ted Gooley, Anthony D. Sung, Allison O. Taylor, Sanghee Hong, et al. “Real-World Clinician Adherence to Screening and Preventive Practices Guidelines for Subsequent Neoplasms Among Allogeneic Hematopoietic Cell Transplant Survivors in the United States.” In Blood, 144:4921–4921. American Society of Hematology, 2024. https://doi.org/10.1182/blood-2024-199289.
Bhatt NS, Hellewell EM, Ng K, Gooley T, Sung AD, Taylor AO, et al. Real-World Clinician Adherence to Screening and Preventive Practices Guidelines for Subsequent Neoplasms Among Allogeneic Hematopoietic Cell Transplant Survivors in the United States. In: Blood. American Society of Hematology; 2024. p. 4921–4921.
Bhatt, Neel S., et al. “Real-World Clinician Adherence to Screening and Preventive Practices Guidelines for Subsequent Neoplasms Among Allogeneic Hematopoietic Cell Transplant Survivors in the United States.” Blood, vol. 144, no. Supplement 1, American Society of Hematology, 2024, pp. 4921–4921. Crossref, doi:10.1182/blood-2024-199289.
Bhatt NS, Hellewell EM, Ng K, Gooley T, Sung AD, Taylor AO, Hong S, Ahmed N, Morey C, Fitzmaurice S, Kennedy VE, Lauer M, Trunk AD, Hamilton BK, Sharma A, Phelps-Bergeron Z, Hill L, Faramand R, Liu H, Winestone LE, Cheng G, Espinoza-Gutarra M, Jamy O, Odstrcil Bobillo M, McClune B, Nawas MT, Yates SJ, Nishitani M, Takahashi T, Koo J, Myers K, Mahadeo KM, Bauchat A, Pearson LK, Walia R, Seago K, Yingling S, Edgar C, Browning A, Lee CJ. Real-World Clinician Adherence to Screening and Preventive Practices Guidelines for Subsequent Neoplasms Among Allogeneic Hematopoietic Cell Transplant Survivors in the United States. Blood. American Society of Hematology; 2024. p. 4921–4921.
Published In
Blood
DOI
EISSN
1528-0020
ISSN
0006-4971
Publication Date
November 5, 2024
Volume
144
Issue
Supplement 1
Start / End Page
4921 / 4921
Publisher
American Society of Hematology
Related Subject Headings
- Immunology
- 3213 Paediatrics
- 3201 Cardiovascular medicine and haematology
- 3101 Biochemistry and cell biology